Pfizer: Celebrex heightens heart risk
485816
PHILADELPHIA - Pfizer Inc. said Friday that its popular pain-reliever Celebrex may double the risk of heart attack at high doses, triggering a torrent of new warnings about an entire class of drugs used by millions.
698387
FRIDAY, Dec. 17 (HealthDayNews) -- Pfizer Inc. said Friday that a study of its popular pain drug Celebrex in cancer patients had found an apparent increased risk of heart attack and other cardiovascular problems.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
611376
(Ivanhoe Newswire) -- A new study reveals a greater risk of heart attack associated with Vioxx (rofecoxib) than with Celebrex (celecoxib), although neither drug shows a statistically significant elevated risk of heart attack relative to people who did not
535351
A new study finds that Celebrex, a painkiller from the family of cox-2-inhibitors, is safer than Vioxx, when it comes to the risk for heart attack.
600661
Celebrex, the nation&#39;s leading arthritis painkiller, raises the risk of heart attack when taken at high doses, the drug&#39;s maker said yesterday in the latest blow to a class of powerful and widely promoted drugs.
626406
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, the Wall Street Journal said.
475207
United States drug giant Pfizer says a trial has found a sharp rise in heart attacks for patients using its blockbuster Celebrex arthritis and pain medicine.
704575
NEW YORK -- A new study has linked painkillers Vioxx, Celebrex, and Bextra to increased cardiovascular risk, reinforcing findings of other trials that have already sparked concern over the safety of a popular category of drugs.
538184
A study in a leading medical journal found Pfizer&#39;s Celebrex does not pose the same risk of causing heart attacks as Vioxx, the competing medicine Merck withdrew from the market because of safety concerns.
599967
New prescriptions for Pfizer Inc.'s  arthritis drug Celebrex fell 56 percent last week after the  company released data showing the drug may increase the risk of  heart attacks and strokes, the Wall Street Journal said.
40308
Pfizer Inc. on Friday said its popular  Celebrex arthritis drug more than doubled the risk of heart  attack in a large cancer-prevention trial, a setback that comes  just weeks after Merck & Co. recalled its similar Vioxx drug  due to heart safety risks.
314536
In a move that sent patients, doctors and investors scrambling, Pfizer said yesterday a government study indicated its Celebrex painkiller more than doubled the risk of heart attacks.
189386
People who take Merck & Co. Inc.'s analgesic Vioxx are nearly three times as likely to have heart attacks as those taking Pfizer Inc.'s Celebrex, according to an independent study published on Monday.
635801
Celebrex, a huge-selling painkiller sold by Pfizer, more than tripled the risk of heart attacks, strokes and death among those taking high doses in a national trial, the company said yesterday.
422800
NEW YORK, December 30  - New prescriptions for pharmaceutical major Pfizerâs (PFE.NYS) arthritis drug Celebrex declined 56% last week after the company revealed that the regular usage of the drug could enhance the risk of heart attacks
242972
12/21/04 -- It&#39;s the third largest pain relief drug in recent months to be linked with an increased risk of heart attack and stroke.